Summit Therapeutics Inc.
Pharmaceutical company · Miami, Florida, United States · Nasdaq: SMMT
Summit Therapeutics Inc. is a pharmaceutical company headquartered in Miami, Florida, United States. Its earliest recorded incorporation is in 2020. Its shares trade on Nasdaq under the ticker SMMT. It has reported private securities offerings to the US SEC, most recently $235 million sold in a notice filed in 2024.
Summit Therapeutics at a glance
What does Summit Therapeutics do?
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $235 million sold (2024).
Frequently asked questions about Summit Therapeutics
Where is Summit Therapeutics headquartered?
Summit Therapeutics Inc. is headquartered in Miami, Florida, United States.
What does Summit Therapeutics do?
Summit Therapeutics Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Summit Therapeutics a public company?
Yes. Summit Therapeutics Inc. trades on Nasdaq under the ticker SMMT.
When was Summit Therapeutics founded?
The earliest incorporation on record for Summit Therapeutics Inc. is in 2020, according to public company registers.
Similar companies
- Longeveron Inc.Miami, Florida, United States
- Opko Health, Inc.Miami, Florida, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.